- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03794895
Prediction of Response to IUCD Associated Menorrhagia Using Doppler
January 3, 2019 updated by: Yasmine Essam Eldin Mohamed Mohamed Ismail, Ain Shams University
Assessment of Efficacy of Uterine Artery Doppler in Predicting the Response to Mefenamic Acid During Treatment of Women With IUCD Associated Menorrhagia
Studying the efficacy of uterine artery doppler in predicting response to mefenamic acid in women having IUCD associated menorrhagia
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
156
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Abbaseya
-
Cairo, Abbaseya, Egypt, 11511
- AinshamsU
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 35 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- women in chile bearing period (age 20-35 yrs ) with history of regular menstrual cycle presenting with recent onset of more then three months menorrhagia after IUCD "copper T 380 A" insertion
Exclusion Criteria:
- history of bleeding tendency
- history of abnormal uterine bleeding due to other causes
- history of active liver disease
- history of antiplatelet or anticoagulant intake in the last month
- history of thyroid disease
- history of endometritis
- history of allergy to NSAIDs
- Adenomyosis
- women having contraindications to use NSAIDs e.g. peptic ulcer
- Insulin dependant diabetes mellitus
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Single arm clinical trial
|
Doing doppler for women having IUCD associated menorrhagia
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Resistance index and Pulsitality index (Predicting the response to IUCD associated menorrhagia)
Time Frame: 1 year
|
Base line uterine artery doppler is done to the patient complaining of IUCD related menorrhagia prior to treatment , parameters of doppler are: resistance index and pulsitality index, then the patient takes mefenamic acid tablets 500 mg three times daily for five days, assessment of response whether the patient is responder or not is done using pictorial blood loss assessment chart then base line doppler parameters in responders and non responders are compared to correlate the response to base line doppler parameters
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yasmine Es Ismail, Bachelor, Ain Shams University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2017
Primary Completion (Actual)
May 1, 2018
Study Completion (Actual)
May 1, 2018
Study Registration Dates
First Submitted
December 27, 2018
First Submitted That Met QC Criteria
January 3, 2019
First Posted (Actual)
January 7, 2019
Study Record Updates
Last Update Posted (Actual)
January 7, 2019
Last Update Submitted That Met QC Criteria
January 3, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Yasmine's Protocol
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Women's Health: Amenorrhea/Dysmenorrhea
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Turtle Health, Inc.Completed
-
US Department of Veterans AffairsCompletedWomen's HealthUnited States
-
Georgetown UniversityUnited States Agency for International Development (USAID)Completed
-
University of TorontoCompleted
-
RTI InternationalEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
McMaster UniversityNot yet recruitingWomen's Health | Brain PlasticityCanada
-
LirioRochester Regional HealthCompletedHealth Behavior | Women's Health | Prevention | Annual Visit | Well VisitUnited States
-
Johns Hopkins UniversityZanvyl and Isabelle Krieger Fund; Abell FoundationCompletedWomen's Health | Preconception CareUnited States
-
Amasya UniversityNot yet recruitingPregnant Women | Women's Health | Childbirth
Clinical Trials on Doppler
-
Cairo UniversityNot yet recruitingClitoris VascularityEgypt
-
Institute of Mother and Child, Warsaw, PolandBielanski HospitalRecruitingFetal Growth RestrictionPoland
-
Hackensack Meridian HealthRecruitingStroke | Subarachnoid Hemorrhage, Aneurysmal | Aneurysmal Subarachnoid Hemorrhage | Cerebral Aneurysm | Cerebral Ischemia | Vasospasm, CerebralUnited States
-
Assiut UniversityCompletedImproving Quality of LifeEgypt
-
Central Hospital, Nancy, FranceUnknownPreeclampsia | Intra-uterine Growth RestrictionFrance
-
University of Auckland, New ZealandWaitemata District Health Board; Counties Manukau HealthCompletedColorectal Cancer | Surgery | Perioperative Care | ColectomyNew Zealand
-
The University of Texas Health Science Center,...University of Alabama at BirminghamCompleted
-
Fondazione Italiana Sclerosi MultiplaCompletedMultiple Sclerosis
-
Echosense Ltd.WithdrawnSystemic Sclerosis | Pulmonary HypertensionIsrael